Premium
Comment on ‘Cardiac effects of 6 months' dietary nitrate and spironolactone in patients with hypertension and with/at risk of type 2 diabetes, in the factorial design, double‐blind, randomised controlled VaSera trial’ by Faconti et al .
Author(s) -
Guimaraes Danielle Aparecida,
TanusSantos Jose Eduardo
Publication year - 2019
Publication title -
british journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.216
H-Index - 146
eISSN - 1365-2125
pISSN - 0306-5251
DOI - 10.1111/bcp.13835
Subject(s) - doxazosin , blood pressure , medicine , spironolactone , nitric oxide , nitrate , diabetes mellitus , pharmacology , essential hypertension , type 2 diabetes , nitrite , nitrate reductase , cardiology , endocrinology , heart failure , chemistry , organic chemistry